abstract |
The invention relates to ethynyl-substituted tetrahydroquinolinone derivatives as well as their pharmaceutically acceptable a salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGIuR modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders. |